Opioid (Narcotic) Withdrawal‡ (LIMITED IMPLEMENTATION PROGRAM ONLY)
Applies only to adult patients
Criteria
- As a limited implementation program, this protocol may only be used with the approval of the regional REMAC and NYS DOH.
- Patients with opioid use disorder who have overdosed and required Naloxone reversal are at increased risk for recurrent overdose and death and also present an opportunity for intervention. Buprenorphine, a partial opioid agonist, provides some relief from opioid withdrawal symptoms. It is safe and effective for paramedic administration.
- Inclusion Criteria
- Age 18 years or older
- Confirmed or suspected opioid overdose requiring Naloxone administration
- Acute opioid withdrawal as a chief complaint
- Exclusion Criteria
- Age <18 years
- Known pregnancy (relative exclusion criteria – physician discretion)
- Methadone use in the last 48 hours
- Altered mental status (unable to consent)
- Unwilling to provide full name AND date of birth
- Received chest compressions/CPR prior to or after EMS arrival
Paramedic
- Perform the Clinical Opioid Withdrawal Scale (COWS).¹ If the patient meets inclusion criteria and does not meet any exclusion criteria:
- If COWS ≥7, counsel the patient on Buprenorphine & referral. Assess their desire for Buprenorphine treatment, if agreeable, contact Pilot Program Physician.
- If COWS <7, give a medication-assisted treatment (MAT) brochure and offer transportation to the closest appropriate emergency department
Pilot program physician medical control orders
- Administer Buprenorphine/Naloxone 16 mg sublingual (SL) film
- Ondansetron 4 mg orally disintegrating tablet (ODT) as needed
- Give a small sip of water to moisten mucous membranes
- Reassess after 10 minutes; if symptoms persist or worsen, administer additional Buprenorphine/Naloxone 8 mg SL
- If symptoms improve after either the first or second dose of Buprenorphine, refer to clinic appointment, or transport to ED
Key points
- 1 Use Pilot Program resources and training for COWS calculation
- Refusal of transportation must be through Pilot Program Physician for any patient that has received Buprenorphine prior to signing RMA
- Only enrolled and trained agencies may participate and must add Buprenorphine/Naloxone to their controlled substance plan
- All Medical Direction for this program will be through Pilot Program Physician